Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase 4 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymic aplasia 1 Polycythemia Vera 1 Myeloproliferative Disorders 1 Immunologic Deficiency Syndromes 1

Interventions

ruxolitinib 1 Phlebotomy 1 Panobinostat 1 Hydroxyurea 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Polycythemia Vera × Phlebotomy × Clear all

NCT06290765 2025-07-31

PV

PharmaEssentia

Phase 4 Not yet recruiting

Myeloproliferative Disorders, Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡